SCHEMBL6338264

SCHEMBL6338264

CCCCc1oc2ccccc2c1Cc1cc(Br)c(OCC(=O)O)c(Br)c1

nearest known ligand 0.68

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 12/20 0.68
THRA P10827 3/20 0.57
THRB P10828 3/20 0.57
NR1H4 Q96RI1 3/20 0.49
SIRT3 Q9NTG7 1/20 0.49
TTR P02766 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6934146 0.85 PTPN1 (0.55) PTPN1THRATHRBNR1H4SIRT3
SCHEMBL5988680 0.85 PTPN1 (0.55) PTPN1THRATHRBNR1H4SIRT3
SCHEMBL6336963 0.83 THRA (0.78) PTPN1THRATHRBNR1H4SIRT3
SCHEMBL6338102 0.82 PTPN1 (0.70) PTPN1
SCHEMBL6338099 0.82 PTPN1 (0.70) PTPN1
SCHEMBL5420762 0.81 PTPN1 (1.00) PTPN1THRATHRBNR1H4TTR
SCHEMBL5989086 0.75 PTPN1 (0.56) PTPN1THRATHRBSIRT3
SCHEMBL3864688 0.74 PTPN1 (0.71) PTPN1NR1H4TTR
SCHEMBL6336171 0.74 NR1H4 (0.79) PTPN1THRATHRBNR1H4SIRT3
SCHEMBL7208468 0.73 THRA (0.73) PTPN1THRATHRBSIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040102480-A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia WYETH (US) 2004-05-27 US claimed
EP-1077965-A1 PHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP claimed
US-6166069-A Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia AMERICAN HOME PRODUCTS CORPORATION (US) 2000-12-26 US claimed
WO-1999058519-A1 PHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 WO claimed
US-6844358-B2 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia WYETH (US) 2005-01-18 US disclosed
US-20040102480-A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia WYETH (US) 2004-05-27 US disclosed
US-6509360-B1 a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. WYETH 2003-01-21 US disclosed
EP-1077965-A1 PHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP disclosed
US-6166069-A Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia AMERICAN HOME PRODUCTS CORPORATION (US) 2000-12-26 US disclosed
WO-1999058519-A1 PHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102480-A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia GPR119, INSR, GCKR PTPN1 1600/4885THRA 71/4885THRB 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.